Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5277328 | 0.98 | CYP1A2 (0.35) | CYP1A2 | |
| Sulfuric Acid SCHEMBL5278578 | 0.94 | CYP1A2 (0.33) | CYP1A2 | |
| Sulfuric Acid SCHEMBL5278587 | 0.89 | CYP1A2 (0.30) | CYP1A2 | |
| Hydrochloric Acid SCHEMBL6760437 | 0.87 | — | — | |
| SCHEMBL15198091 | 0.82 | POLB (0.41) | — | |
| SCHEMBL5201045 | 0.78 | MAOB (0.34) | — | |
| SCHEMBL5498897 | 0.78 | HTT (0.39) | — | |
| SCHEMBL14384185 | 0.76 | FSCN1 (0.31) | — | |
| SCHEMBL33881 | 0.75 | CYP1A2 (0.42) | CYP1A2 | |
| SCHEMBL15190352 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2628730-B1 | TELESCOPING SYNTHESIS OF 5-AMINO-4-NITROSO-1-ALKYL-1H-PYRAZOLE SALTS | NOXELL CORP (US) | 2017-12-06 | — | — | EP | disclosed |
| EP-1556389-B9 | CEPHEM COMPOUNDS | ASTELLAS PHARMA INC (JP) | 2015-09-09 | — | — | EP | disclosed |
| EP-1556389-B3 | CEPHEM COMPOUNDS | ASTELLAS PHARMA INC (JP) | 2015-04-01 | — | — | EP | disclosed |
| US-8785656-B2 | Telescoping synthesis of 5-amino-4-nitroso-1-alkyl-1H-pyrazole salt | THE PROCTER & GAMBLE COMPANY (US) | 2014-07-22 | — | — | US | disclosed |
| US-20130217891-A1 | Telescoping Synthesis of 5-Amino-4-Nitroso-1-Alkyl-1H-Pyrazole Salt | THE PROCTER & GAMBLE COMPANY (US) | 2013-08-22 | — | — | US | disclosed |
| WO-2013122989-A1 | TELESCOPING SYNTHESIS OF 5-AMINO-4-NITROSO-1-ALKYL-1H-PYRAZOLE SALTS | THE PROCTER & GAMBLE COMPANY (US) | 2013-08-22 | — | — | WO | disclosed |
| EP-2628730-A1 | Telescoping synthesis of 5-amino-4-nitroso-1-alkyl-1H-pyrazole salts | The Procter and Gamble Company (US) | 2013-08-21 | — | — | EP | disclosed |
| EP-1844109-B1 | USE OF CATIONIC AZACYANINE DYES FOR COLORING KERATIN FIBERS | PROCTER & GAMBLE (US) | 2011-03-30 | — | — | EP | disclosed |
| EP-1408025-B1 | 3,3-DIALKOXY-2-HYDROXYIMINOPROPIONITRILES, PROCESS FOR PREPARATION THEREOF AND PROCESS OF PREPARING 5-AMINO -4-NITROSOPYRAZOLES OR SALTS THEREOF BY THE USE OF THE SAME | UBE INDUSTRIES (JP) | 2007-11-21 | — | — | EP | disclosed |
| EP-1844109-A2 | USE OF CATIONIC AZACYANINE DYES FOR COLORING KERATIN FIBERS | Wella Aktiengesellschaft (DE) | 2007-10-17 | — | — | EP | disclosed |
| US-20070033742-A1 | Pyrazole azomethines and colorants containing these compounds | PROCTER & GAMBLE COMPANY, THE | 2007-02-15 | — | — | US | disclosed |
| US-7129232-B2 | For therapy of of infectious diseases | ASTELLAS PHARMA INC. (JP) | 2006-10-31 | — | — | US | disclosed |
| WO-2006081246-A2 | USE OF CATIONIC AZACYANINE DYES FOR COLORING KERATIN FIBERS | THE PROCTER & GAMBLE COMPANY (US) | 2006-08-03 | — | — | WO | disclosed |
| US-20050096472-A1 | Process for producing 3-unsubstituted 5-amino-4-nitrosopyrazole compound, and 2-hydroxyimino-3-oxopropionitrile, 3-hydrazono-2-hydroxyiminopropionitrile compound, and processes for producing these | UBE INDUSTRIES, LTD. (JP) | 2005-05-05 | — | — | US | disclosed |
| EP-1475369-A1 | PROCESS FOR PRODUCING 3-UNSUBSTITUTED 5-AMINO-4-NITROSOPYRAZOLE COMPOUND, AND 2-HYDROXYIMINO-3-OXOPROPIONITRILE, 3-HYDRAZONO-2-HYDROXYIMINOPROPIONITRILE COMPOUND, AND PROCESSES FOR PRODUCING THESE | Ube Industries, Ltd. (JP) | 2004-11-10 | — | — | EP | disclosed |
| US-20040132994-A1 | Cephem compounds | FUJISAWA PHARMACEUTICAL CO., LTD (JP) | 2004-07-08 | — | — | US | disclosed |
| US-20040116732-A1 | 3,3-Dialkoxy-2-hydroxyiminopropionitriles, process for preparation thereof and process of preparing 5-amino-4-nitrosopyrazoles or salts thereof by the use of the same | UBE INDUSTRIES, LTD. (JP) | 2004-06-17 | — | — | US | disclosed |
| EP-1408025-A1 | 3,3-DIALKOXY-2-HYDROXYIMINOPROPIONITRILES, PROCESS FOR PREPARATION THEREOF AND PROCESS OF PREPARING 5-AMINO -4-NITROSOPYRAZOLES OR SALTS THEREOF BY THE USE OF THE SAME | Ube Industries, Ltd. (JP) | 2004-04-14 | — | — | EP | disclosed |
| EP-1342716-A2 | Preparation of 4,5-diamino-1-(2'-hydroxyethyl)-pyradazole and acid addition salts thereof | EASTMAN CHEMICAL COMPANY (US) | 2003-09-10 | — | — | EP | disclosed |
| US-6452019-B1 | SIMPLIFIED PROCESS THAT DOES NOT INVOLVE TOXIC SOLVENTS NOR MULTIPLE ISOLATIONS OF INTERMEDIATE PRODUCTS; CYCLIZATION OF ALKYL(ETHOXYMETHYLENE)CYANOACETATE AND 2-HYDROXY-ETHYL-HYDRAZINE; DECARBOXYLATING; NITROSATION TO AMINATE | EASTMAN CHEMICAL COMPANY | 2002-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040132994-A1 | Cephem compounds | CEP170, ABCB11, RCC2 | CYP1A2 443/4885 |
| US-20070033742-A1 | Pyrazole azomethines and colorants containing these compounds | KRT18, NOX5, TUBB3 | CYP1A2 276/4885 |
| US-20130217891-A1 | Telescoping Synthesis of 5-Amino-4-Nitroso-1-Alkyl-1H-Pyrazole Salt | NOX5, PPOX, PAOX | CYP1A2 837/4885 |
| US-20050096472-A1 | Process for producing 3-unsubstituted 5-amino-4-nitrosopyrazole compound, and 2-hydroxyimino-3-oxopropionitrile, 3-hydrazono-2-hydroxyiminopropionitrile compound, and processes for producing these | CYP1A1, CYP2E1, NOS3 | CYP1A2 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.